Interplay of Adverse Events, Spontaneous Reporting, and Longitudinal Electronic Health Records for Signal Management

This presentation describes how multiple data sources contribute to FDA’s pharmacovigilance efforts and spontaneous reporting systems are complemented by longitudinal databases for signal management.
 

It was presented at the DIA 2025 Global Annual Meeting.